Background
Methods
Literature search strategy
Database | Search terms |
---|---|
Google Scholar (July 3, 2015) | HIV + SmartCare + Zambia HIV + routine + data HIV/AIDS + “routinely collected data” + Zambia Condom + HIV + Zambia |
PubMed (July 15, 2015) | HIV/AIDS + “routinely collected data” + Zambia + routine data Condom + HIV |
African Journals Online (November 6, 2015) | HIV + routine + data + Zambia + condom + "routinely collected data" + SmartCare |
Directory of Open Access Journals (November 11, 2015) | HIV + Zambia + condom + "routinely collected data" + SmartCare |
Data analysis
Results
First author, year of publication | Data collection period | Sample size | Sampled population | Outcomes assessed |
---|---|---|---|---|
HIV testing and counselling | ||||
Topp et al. [31] | 2008–2011 | 2239 | Adults only | CD4 count, haemoglobin level, BMI, education level, partner’s HIV status |
Topp et al. [32] | 2008–2010 | 44,420 | Adults only | HIV testing, enrolment into care |
Czaicki et al. [33] | 2011–2012 | 10,806 | Adult couples | Cohabitation length, prior HIV testing, current antiretroviral use |
Kankasa et al. [34] | 2006–2007 | 15,670 | Children | HIV testing, testing coverage, HIV counselling, |
PMTCT | ||||
Killam et al. [35] | 2007–2008 | 13,917 | Women initiating ART | Women eligible for ART, women initiating ART |
Stringer et al. [36] | 2001 | 17,263 | Women only | Women tested, mothers and babies receiving NVP |
Stringer et al. [37] | 2003 | 8787 | Mother baby pairs | Gravidity, offered testing, tested, infant given NVP |
Chibwesha et al. [38] | 2007–2010 | 1813 | Mother baby pairs | CD4 count, date of highly active ART initiation, infant HIV status |
Liu et al. [39] | 2007– 2009 | 13,888 | Women initiating ART | CD4 count, haemoglobin level, syphilis, tuberculosis, HIV status |
Chintu et al. [40] | 2004–2006 | 6740 | Women on ART | Mortality, NVP exposure, CD4 count, haemoglobin level |
Mandala et al. [41] | 2007–2008 | 14,815 | Women on ART | CD4 count, initiated on ART |
Torpey et al. [20] | 2005–2008 | 9723 | Women on ART | HIV testing, enrolled to care, received ART |
Chibwesha et al. [42] | 2009–2010 | 18,407 | Women initiating ART | CD4 count, haemoglobin level, use of contraceptives |
Stringer et al. [43] | 2002–2006 | 243,302 | Women and baby pairs | HIV status, number testing positive, attended antenatal care |
Mulindwa [44] | Not stated | 146 | Women initiating ART | NVP toxicity, hepatic toxicity, WHO grading of toxicity |
Ngoma et al. [45] | 2008–2009 | 279 | Women only | HIV-free at 12 months, mortality rates, HIV transmission |
Torpey et al. [46] | 2007–2010 | 28,320 | Children only | HIV testing, type of PMTCT regimen |
Torpey et al. [47] | 2007–2009 | 8237 | Children | HIV testing, type of PMTCT regimen |
Albrecht et al. [48] | 2001–2003 | 760 | Women only | PMTCT drug adherence, partner disclosure |
Social and behavioural change | ||||
Kankasa et al. [34] | 2004–2007 | 27,115 | Adults on ART | Adherence, mortality, loss to follow-up, CD4 count |
Goldman et al. [49] | 2006–2007 | 913 | Adults on ART | Adherence, viral load |
Carlucci et al. [50] | 2006 | 542 | Adults on ART | Drug adherence |
Birbeck et al. [51] | 2005–2006 | 255 | Adults on ART | Drug adherence |
First author | Data collection period | Sample size | Sampled population | Outcomes assessed |
---|---|---|---|---|
Cantrell et al. [52] | 2004–2005 | 636 | Adults on ART | Adherence to medication, CD4, weight gain |
Koethe et al. [53] | 2004–2008 | 27,915 | Adults initiating ART | Weight gain, death, treatment failure, BMI |
Tirivayi et al. [54] | 2009 | 291 | Adults on ART | Adherence to medication, CD4, BMI |
Koethe et al. [55] | 2004–2009 | 56,612 | Adults on ART | CD4, mortality, BMI |
Stringer et al. [56] | 2004–2007 | 14,736 | Adults on ART | Single dose substitution, CD4 count, haemoglobin level, BMI, mortality |
Chi et al. [57] | 2007–2010 | 18,866 | Adults initiating ART | CD4, clinical disease staging, BMI, serum creatinine adherence, mortality |
Chi et al. [58] | 2007–2009 | 10,485 | Adults on ART | Drug substitution, mortality, loss to follow-up, withdrawal and death |
Chi et al. [59] | 2004–2008 | 24,366 | Adults on ART | CD4 counts, age clinical staging, haemoglobin, tuberculosis co-infection, adherence |
Chi et al. [60] | 2007 | 33,704 | Adults on ART | Cut-off points defining loss to follow-up, sensitivity, specificity, misclassification rate |
Giganti et al. [61] | 2004–2010 | 40,410 | Adults on ART | Haemoglobin level, CD4, ART regimen |
Vinikoor et al. [62] | 2015 | 20,308 | Adults on ART | HBsAg, CD4, BMI, WHO staging |
Mulenga et al. [63] | 2004–2007 | 25,779 | Adults on ART | Mortality, creatinine clearance |
Stringer et al. [64] | 2004–2005 | 21,755 | Adults initiating ART | Clinical staging, CD4, mortality, BMI, haemoglobin level, adherence |
Seu et al. [65] | 2009–2012 | 68 | Adults failing treatment | CD4 count, adherence, HIV drug resistance mutations |
Krebs et al. [66] | 2005 | 1343 | Adults lost to follow-up | CD4 count, BMI, mortality, home visit categories (traced, untraceable, died) |
Vinikoor et al. [67] | 2004–2010 | 53,015 | Adults missing pharmacy refills | CD4 count, clinical staging, pharmacy refills, adherence, ART regimen |
Vinikoor et al. [68] | 2004–2011 | 92,130 | Adults on ART | Adherence, CD4 count, mortality, long-term follow-up |
Harris et al. [69] | 2005–2007 | 20,153 | Tuberculosis/HIV co-infected adults | Enrolment on ART, CD4 count, WHO staging |
Mweemba et al. [70] | 2011–2013 | 91,130 | Adults initiating ART | Hepatitis B co-infection, WHO staging, CD4 count |
Deo et al. [71] | 2007 | 13 | Laboratories | CD4 count, haemoglobin, liver function test |
Chi et al. [72] | 2004–2006 | 6740 | Women exposed to nevirapine | WHO stage, CD4 cell count, status, BMI |
Bolton-Moore et al. [73] | 2004–2007 | 4975 | Children on ART | CD4 percentage, weight-for-age Z scores, clinical staging, haemoglobin level, mortality |
Mubiana‐Mbewe et al. [74] | 2004–2006 | 1705 | Children enrolled into care | CD4 percentage, clinical staging, haemoglobin level |
Scott et al. [75] | 2006–2011 | 1334 | Children on ART | CD4 percentage, fixed and variable unit costs |
Kiage et al. [76] | 2009–2011 | 822 | Mother-infant pairs | WHO staging, CD4/CD8 percentage, HIV, haemoglobin panel, maternal-CD4 count |
Sutcliffe et al. [77] | 2004–2008 | 1278 | Children on ART | Enrolment in ART, loss to follow-up, mortality, clinical staging, CD4 percentage |
Iyer et al. [78] | 2006–2011 | 1102 | Children initiating ART | Age, CD4 percentage, ART initiation, full blood count, blood chemistry |
Sutcliffe et al. [79] | 2004–2008 | 863 | Children on ART | Mortality, CD4, HIV, haemoglobin level |
Sutcliffe [80] | 2000–2002 | 492 | Children on ART | CD4 count, haemoglobin level, mortality |
Van Dijk et al. [81] | 2007–2012 | 77 | Children on ART | Weight-for-age Z scores, CD4 percentage |
Van Dijk et al. [82] | 2007–2010 | 198 | Children on ART | Treatment outcomes, viral load, CD4 percentage, retention in care, mortality |
Sutcliffe et al. [83] | 2007–2009 | 193 | Children initiating ART | Weight-for-age and height-for-age Z scores |
Nkamba [84] | Not stated | 59 | Children on ART | T cell subsets CD4 and CD8 memory |
Van Dijk et al. [85] | 2007–2008 | 192 | Children on ART | Years of receiving ART, distance from clinic, CD4 percentage, weight-for-age Z score |
Sinkala et al. [86] | 2005–2006 | 5609 | Adults only | Colonoscopy, laparoscopy, culture results |
Sheyo [87] | 2009–2010 | 452 | Adults and children | HIV status, burn history, burn outcome and management |
Brugha et al. [88] | 2004–2007 | 39 | Health facilities | VCT, ART, PMTCT, childhood immunisation service and coverage trends |
Kancheya et al. [89] | 2003–2006 | 203 | Adults | HIV status, VCT |
Kaile et al. [90] | 2004 | 18 | Adults on ART | Blood pressure serum potassium, creatinine and sodium, Karnofsky score, WHO staging |